Effect of alirocumab on postprandial hyperlipidaemia in patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled, cross‐over trial
2025; Wiley; Linguagem: Inglês
10.1111/dom.16305
ISSN1463-1326
AutoresBertrand Cariou, An Thys, Arsênio Rodrigues Oliveira, Marine P. M. Letertre, Béatrice Guyomarch, Maxime Carpentier, Claire Cannet, Pierre Morcel, Audrey Ernould, Laurent Flet, Patrick Giraudeau, Samy Hadjadj, Cédric Le May, Mikaël Croyal,
Tópico(s)Lipid metabolism and disorders
Referência(s)